Complementary and alternative medicine use among cancer survivors: a population-based study

By Mao Jun  

Journal of Cancer Survivorship, Vol. 5, Iss. 1, 2011-03 ,pp. : 8-17

Springer Publishing Company

Access to resources Recommend Favorite

Population-based study on use of chemotherapy in men with castration resistant prostate cancer

By Lissbrant Ingela Franck   Garmo Hans   Widmark Anders   Stattin Pär  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1593-1601

Informa Healthcare

Access to resources Recommend Favorite

Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study

By Ko Andrew   Dito Elizabeth   Schillinger Brian   Venook Alan   Bergsland Emily   Tempero Margaret  

Cancer Investigation, Vol. 26, Iss. 1, 2007-12 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

By Song Hong   Do Young   Chang Heung   Ryu Min   Lee Kyung   Kim Yeul   Hong Dae   Cho Jae   Lee Kyoung   Kim Si  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 763-768

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer

By Ko Andrew   Venook Alan   Bergsland Emily   Kelley R.   Korn W.   Dito Elizabeth   Schillinger Brian   Scott Janet   Hwang Jimmy   Tempero Margaret  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1051-1057

Springer Publishing Company

Access to resources Recommend Favorite